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Multi-ingredient pre-workout supplements,
safety implications, and performance
outcomes: a brief review
Patrick S. Harty1†, Hannah A. Zabriskie1†, Jacob L. Erickson2, Paul E. Molling2, Chad M. Kerksick1
and Andrew R. Jagim1,2*

Abstract
In recent years, a new class of dietary supplements called multi-ingredient pre-workout supplements (MIPS) has increased
in popularity. These supplements are intended to be taken prior to exercise and typically contain a blend of ingredients
such as caffeine, creatine, beta-alanine, amino acids, and nitric oxide agents, the combination of which may elicit a
synergistic effect on acute exercise performance and subsequent training adaptations compared to single ingredients
alone. Therefore, the purpose of this article was to review the theoretical rationale and available scientific evidence
assessing the potential ergogenic value of acute and chronic ingestion of MIPS, to address potential safety concerns
surrounding MIPS supplementation, and to highlight potential areas for future research. Though direct comparisons
between formulations of MIPS or between a MIPS and a single ingredient are challenging and often impossible due to
the widespread use of “proprietary blends” that do not disclose specific amounts of ingredients in a given formulation,
a substantial body of evidence suggests that the acute pre-exercise consumption of MIPS may positively influence
muscular endurance and subjective mood, though mixed results have been reported regarding the acute effect
of MIPS on force and power production. The chronic consumption of MIPS in conjunction with a periodized resistance
training program appears to augment beneficial changes in body composition through increased lean mass accretion.
However, the impact of long-term MIPS supplementation on force production, muscular endurance, aerobic
performance, and subjective measures is less clear. MIPS ingestion appears to be relatively safe, though most
studies that have assessed the safety of MIPS are relatively short (less than eight weeks) and thus more information is
needed regarding the safety of long-term supplementation. As with any dietary supplement, the use of MIPS carries
implications for the athlete, as many formulations may intentionally contain banned substances as ingredients or
unintentionally as contaminants. We suggest that athletes thoroughly investigate the ingredients present in
a given MIPS prior to consumption. In conclusion, it appears that multi-ingredient pre-workout supplements
have promise as an ergogenic aid for active individuals, though further information is required regarding long-term
efficacy and safety in a wider variety of populations.
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Background
The use of nutritional supplements to improve performance and augment training adaptations is becoming
increasingly prevalent in today’s world of sports and fitness [1, 2]. A new class of dietary supplements known as
multi-ingredient pre-workout supplements (MIPS) has
garnered interest from athletes, fitness enthusiasts, and
researchers alike. MIPS products typically contain a
blend of ingredients such as caffeine, branched-chain
amino acids, nitrates, creatine, β-alanine, and other ingredients that are purported to improve acute exercise
performance, potentially leading to augmented training
adaptations following continued use [3–5]. These ingredients are often displayed on the supplement facts label
in the form of a “proprietary blend,” with specific
amounts sometimes not disclosed to the consumer.
Though United States Food and Drug Administration
(FDA) regulations require that all dietary ingredients included in proprietary blends are listed in descending
order of predominance by weight, such labeling practices
make it challenging to determine whether a supplement
contains sufficient amounts of key ergogenic ingredients.
For example, one ingredient listed at the beginning of a
proprietary blend may be over-represented in the blend,
while other ingredients may be included at quantities far
below the threshold of efficacy. Because many of the
common ingredients used in MIPS formulations act on
different physiological mechanisms, many researchers
have speculated whether certain combinations of these
ingredients may confer a synergistic effect on the overall
efficacy of a given formulation [5]. However, as the majority of MIPS that have been investigated in the literature do not list ingredients beyond a proprietary blend,
it becomes difficult to make direct comparisons between
the effects of a given MIPS and the equivalent amount
of an individual ingredient or from one product to another. This problem is evident in the literature, as nearly
all studies that have investigated MIPS have not compared the effects of these supplements against those of a
recognized primary ingredient such as creatine, caffeine,
or β-alanine. However, one notable exception to this
trend is a recent investigation by Lane and Byrd [6],
which compared the effects of a caffeine-containing
MIPS against a caffeine-matched placebo and an inert
placebo alone. The researchers found that bench press
peak velocity was significantly improved over inert placebo after ingestion of both MIPS or caffeine, though
bench press mean velocity was only significantly improved after consumption of MIPS. Furthermore, both
the MIPS and the caffeine condition were found to have
no demonstrable effect on blood lactate levels, vertical
jump performance, and repeat Wingate anaerobic cycling performance, suggesting the presence of similarities
between the effects of the MIPS in question and caffeine
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alone. Conversely, Shields et al. [7] compared between
the effects of caffeine and a caffeine-free MIPS formulation in a pilot study and reported that only subjects who
consumed caffeine exhibited decreased calmness, a common side effect of the substance. Future research should
utilize similar study designs to allow for direct comparison between the effects of a MIPS and one or more of
its constituent ingredients, as the results of such investigations allow for one to determine the uniqueness and
efficacy of proprietary blends. Despite the difficulties in
comparing between MIPS and other ergogenic substances, many off-the shelf MIPS formulations have been
found to significantly improve acute exercise performance and enhance training adaptations over time when
combined with a structured training program. Due to
their relative novelty, it is important to examine the efficacy and safety following both acute and chronic ingestion
of these products before providing recommendations to
the consumer. Unfortunately, many of the published
works on this topic do not include clearly delineated primary outcome measures and instead focus on all statistically significant outcomes to bolster their strength and
conclusions. Such an approach may skew the conclusions
of the reader, as only the positive aspects of a given supplement are emphasized. As the purpose of this article
was to review the entire body of scientific evidence assessing the potential ergogenic value of acute and chronic ingestion of MIPS, no outcome measure from any relevant
study was excluded from our analysis, allowing for a more
complete and balanced overview of the literature. In
addition, this review addresses the potential safety concerns surrounding MIPS supplementation and potential
areas for future research. This was accomplished by the
completion of a thorough review of the published literature investigating the effects of MIPS ingestion on exercise
performance and potential for the enhancement of training adaptations over time.

Methods
Ending on May 2, 2018, PubMed, Ebsco Host, Medline,
and Google Scholar databases were searched for published literature using but not limited to the following
keywords: multi-ingredient pre-workout supplement,
MIPS, pre-workout, multi-ingredient performance supplement. To facilitate interpretation of published results,
the authors of this review calculated effect sizes when
not provided by included texts. Standardized mean difference (Cohen’s d) was calculated for each statistically significant (p < 0.05) outcome measure using the following
formula: d = (ImprovementMIPS – ImprovementControl)/
SDpooled [8]. Effects were considered very weak if they
were less than 0.2, small if between 0.2–0.5, moderate if
between 0.5–0.8, and strong if greater than 0.8. In cases
where Cohen’s d could not be calculated due to unreported
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sample size or standard deviation, Relative Effects (RE)
were calculated as follows: RE = [(PostMIPS/PreMIPS)*100 /
(PostControl/PreControl)*100]*100 according to the methods
employed by Trexler et al. [9] in a recent position stand. A
relative effect greater than 100 indicates MIPS increased
the outcome measure, while a value less than 100 indicates
MIPS decreased the outcome measure. However, there
were still studies in which d and RE were impossible to calculate due to missing data or data being presented in a figure without data labels. In these instances, the effect size is
listed as NA. All effect measurements, the statistical significance of each effect, and the strength of each effect are presented in parentheses throughout the text. Because direct
comparisons between different formulations of MIPS remain challenging due to wide variations in ingredients and
dosages, summary tables have been developed that outline:
dosing, MIPS ingredients listed in descending order of predominance by weight, exercise interventions, effect size,
and other relevant information to present a comprehensive
overview of each study.

Ingredients
As the ergogenic effects of many of the primary MIPS
ingredients have been examined on an individual basis
and reviewed elsewhere, the following section will briefly
outline the mechanism of action, common dosing protocols, and ergogenic potential of common MIPS ingredients. For the purposes of this review, the term MIPS will
be confined to multi-ingredient pre-workout supplements and is not to be confused with energy drinks, energy shots, or commercial sport drinks (previously
reviewed in Ref. [10]), which, despite having some overlapping ingredients such as caffeine, tend to differ in
specific ingredient profiles and purported benefits.
Caffeine

Caffeine (Reviewed extensively in Refs. [11–13]) appears
to be the primary ingredient responsible for several of
the acute ergogenic effects of MIPS, as it is rapidly
absorbed and typically peaks in the bloodstream within
60 min of ingestion [5, 11]. Caffeine acts as an adenosine
receptor antagonist [14] and has been shown to acutely
improve cognition as well as performance during endurance, power, and resistance exercise when consumed in
dosages between 3 and 6 mg/kg bodyweight [11]. MIPS
formulations that contain at least 300 mg caffeine per
serving will fall within the acceptable dosing range for
most individuals.
Amino acids and amino-containing compounds

Taurine is an amino-containing sulfonic acid that has
been reported to have antioxidant, metabolic, and ergogenic effects [15]. While chronic consumption of the substance may improve time-to-exhaustion during endurance
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exercise, acute ingestion of 1.5 g taurine as part of a MIPS
has been shown to improve muscular endurance during
resistance exercise [16]. Branched-chain amino acids
(BCAAs) are often added to MIPS formulations with the
intent of boosting rates of muscle protein synthesis, minimizing protein breakdown, and reducing exercise-induced
muscle damage [17]. While BCAAs have been theorized to
ameliorate fatigue, they do not appear to significantly
enhance exercise performance or stimulate muscle
protein synthesis [17, 18].
Nitric oxide agents

Nitric oxide (NO) is a vital signaling molecule that has
been shown to increase blood flow to active muscles,
which in theory may result in increased exercise performance [19–21]. Several common components of
MIPS (i.e. arginine, citrulline) are purported to increase
levels of nitric oxide and thus improve performance via
increased blood flow during exercise, with equivocal
performance outcomes reported in the literature [22].
Dietary nitrate (Reviewed in Refs. [19–22] appears to enhance acute endurance and high-intensity exercise performance when consumed in doses of 300 mg or higher
[23]. Inorganic nitrate (NO3−) is a compound found in
beetroot juice and sodium nitrate that is reduced to
Nitrite (NO2−) in the oral cavity via enzymatic activity
and then to nitric oxide (NO) in the stomach or peripheral
tissues under hypoxic conditions [19–21]. L-arginine
(Reviewed in Refs. [22, 24]) is an amino acid that is a precursor required for the synthesis of nitric oxide. While
some studies have demonstrated ergogenic benefits resulting from oral consumption of L-arginine, the majority of
evidence suggests that arginine has limited efficacy in improving blood flow or exercise performance. L-Citrulline
(Reviewed in Refs. [22, 25]) is a non-essential amino acid
found primarily in watermelon that is converted to
L-arginine and thus promotes NO synthesis. L-Citrulline
supplementation (often combined with malate, an intermediate in the citric acid cycle) has been shown to increase vasodilation and improve exercise performance
when consumed chronically in doses of 6-8 g per day
[22, 25]. However, the doses found in MIPS are generally
far lower than those that have shown ergogenic effects.
Creatine

Creatine (Reviewed in Ref [26]) is a naturally-occurring
amino acid found in the muscle of various animals [27].
Creatine supplementation is safe and has been consistently demonstrated to increase intramuscular phosphocreatine levels by 30% after supplementing with roughly
5 g (0.03 g/kg/dose) per day following a loading period
of 20 g/day (0.3 g/kg/day). This regimen has gone on to
positively impact high-intensity exercise performance
when chronically consumed in doses equal to roughly
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3-5 g per day following a loading period of 20 g/day
[26]. While post-workout creatine consumption appears
to be superior to pre-exercise supplementation [28],
the regular consumption of at least 3 g of creatine
from a MIPS per day for 28 days is likely sufficient
to enhance exercise performance and augment training adaptations [26].
Betaine

Betaine (trimethylglycine) is a naturally-occurring derivative of the amino acid glycine which may improve
exercise performance by increasing rates of creatine synthesis, elevating levels of blood nitric oxide, and promoting fluid and thermal homeostasis [29, 30]. Chronic
supplementation with 1.25–2.5 g per day of betaine has
been demonstrated to enhance repetitions to fatigue and
total volume load completed during resistance exercise
[29, 30], with improvements in power and force production also reported [31]. However, the dosages used in
these investigations are far higher than those found in a
typical MIPS.
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phase, male and female study participants performed
bench press and leg press 1RM and muscular endurance
testing (3 sets of 10 repetitions, last set to fatigue) to induce fatigue and then consumed either MIPS or placebo.
The researchers noted that MIPS consumption prevented
a decline in post-supplementation leg press 1RM following the pre-fatiguing bout of exercise and tended to mitigate decrements in bench press 1RM, though this effect
was not statistically significant. Likewise, Bergstrom et al.
[33] reported no differences in maximal isokinetic force
production between males who consumed MIPS or placebo when measured after a training session containing
high-volume resistance exercise to fatigue. However, the
lack of between-group differences is notable, as the MIPS
group had performed 9–14% more total volume (d = 0.42,
p = 0.004, small) during the session compared to the
group who had consumed placebo. Therefore, while more
research is warranted in this area, it appears that consumption of MIPS may allow for greater retention of force
production during and after exercise.
Muscular endurance/Total volume completed

Beta-alanine

β-alanine (Reviewed in Ref. [9]) is a common MIPS
component and precursor to carnosine, a dipeptide
which acts as an intramuscular buffer. The consumption
of 4-6 g β-alanine per day over a period of at least 2
weeks has been demonstrated to improve high-intensity
exercise performance [9]. Thus, provided that a MIPS
contains sufficient amounts of β-alanine, similar ergogenic
effects can be expected, if consumed daily to appropriately
maintain intramuscular carnosine levels.

Acute effects of MIPS on performance
Numerous investigations have examined the effect of a
single pre-exercise dose of MIPS on performance outcomes. These studies are outlined in Table 1.
Force production

Acute MIPS ingestion appears to have little effect on
maximal force production (i.e, strength), though results
of several recent investigations suggest that pre-exercise
consumption of a caffeine-containing MIPS may help to
mitigate fatigue-related decrements in force production
experienced over a series of repetitions. For example,
Tinsley et al. [32] noted that consumption of either
caffeine-free or caffeine-containing pre-workout supplements did not improve maximal concentric or eccentric
force production during squatting exercise in both males
and females. Collins and colleagues [23] employed a
crossover design to examine the effect of a caffeine-containing ready-to-drink pre-workout beverage on bench
press and leg press one-repetition maximum (1RM) and
muscular endurance testing. During the acute testing

Many of the studies investigating the effect of MIPS on
muscular endurance have reported that subjects who
consumed MIPS completed more resistance exercise
repetitions to fatigue relative to those who consumed
placebo, though disparities between study designs, supplement contents, and dosing protocols make direct
comparisons challenging. Hoffman and colleagues [16]
noted that males who consumed a MIPS after a 7-day
creatine monohydrate loading period performed significantly more back squat repetitions to fatigue compared
to placebo after prior completion of 5 sets of 10 repetitions at 75% 1RM (NA). Conversely, Magrini et al. [34]
failed to show between-group differences in push-up
repetitions to fatigue following consumption of caffeinecontaining MIPS or placebo. These null results were
mirrored by Bloomer and colleagues [35], who evaluated
the performance effects of three commercially-available,
caffeine-containing MIPS on repetitions completed to
fatigue using a bench press exercise machine. The researchers found no performance benefits of MIPS compared to placebo and noted that the dosage of caffeine
contained in the proprietary blend of each MIPS was
likely insufficient to confer ergogenic effects. Finally,
Hoffman and colleagues [36] found no effect of acute
MIPS supplementation on maximum pushups or sit-ups
completed within a minute.
Interestingly, several investigations have reported that
MIPS consumption improved either upper or lower-body
muscular endurance, but not both within the same participants. Cameron and associates [4] found that female
subjects who consumed a caffeine-containing MIPS
completed significantly more bench press repetitions

Subjects

8 college-aged,
resistance-trained
males

12 college-aged male
strength and power
athletes

19 resistance-trained
males

19 recreationallyactive males and
females

15 recreationallytrained males and
females

8 college-aged,
resistance-trained
males

Study

Hoffman et al.
2008

Hoffman et al.
2009

Bloomer et al.
2010

Hoffman et al.
2010

Walsh et al.
2010

Gonzalez et al.
2011

Randomized, Doubleblind, placebocontrolled, crossover
design.

a
Prop. Blend 1: (7900 mg)
L-Leucine, L-Arginine,
L-Glutamine, L-Valine,
L-Isoleucine
Prop. Blend 2: (2050 mg)

a
Prop. Blend 1: (7900 mg)
L-Leucine, L-Arginine,
L-Glutamine, L-Valine,
L-Isoleucine
Prop. Blend 2: (2050 mg)
Taurine, Glucoronolactone,
Caffeine
β-alanine (2500 mg)
Creatine (5000 mg)
Vitamin C (7900 mg)

Acetyl-L-carnitine (500 mg)
L-tyrosine (500 mg)
Α-glycerophosphocholine
(150 mg)
Choline bitartrate (125 mg)
Caffeine (60 mg)
Phosphatidylserine (50 mg)

Randomized, Doubleblind, placebocontrolled design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

3 MIPS Investigated, all
contained the following:
Amino Acids
Creatine
Taurine
Caffeine (MIPS 3: 234 mg)

Prop. Blend: (726 mg)
β-alanine
Caffeine (158 mg)
L-Leucine
B-Phenylethylamine HCl
L-Valine
L-Isoleucine
N-Acetyl-L-Tyrosine
Yohimbine
5-hydroxytryptophan

BCAAs (5200 mg)
Creatine (5000 mg)
Essential Amino Acids
(4300 mg)
Taurine (1500 mg)
Glucuronolactone (350 mg)
Caffeine (110 mg)

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Design

Table 1 Performance outcomes in acute MIPS studies

10 min prior to
exercise

4 sets of up to 10
repetitions BP at 80% 1RM

Treadmill TTE Protocol at
70% VO2max

Choice Reaction Time Test
before and after the
following:
WAnT, Maximum Pushup
Repetitions Completed in
one Minute, Maximum
Situp Repetitions
Completed in one Minute

10 min prior to
exercise

10 min prior to
exercise

Bench Press Throws at 30%
1RM, 10 sets of BP RTF at
50% 1RM

Choice Reaction Time Test,
20-s WAnT repeated three
times

6 sets of up to 10
repetitions Barbell Back
Squat, 75% 1RM

Performance Testing
Protocol

30 min prior to
exercise

10 min prior to
exercise

20 min prior to
exercise

Timing

Ref #

[16]

[43]

[35]

[36]

[44]

[38]

Results (d or RE)

↑ Repetitions during Set 5 (NA)

↑ Number of Targets Struck
(d = 0.53)
↑ Percent of Targets Stuck
(d = 0.48)
↔ Peak Power
↔ Mean Power

↔ BP 1RM
↔ RTF
↔Upper Body Power

↑ Retention of Reaction Time (NA)
↔ Peak Power
↔ Mean Power
↔ Pushups Completed
↔ Sit-ups Completed

↑ TTE (NA)

↑ Total Lifting Volume (d = 0.30)
↑ BP Peak Power (d = 0.53)
↑ BP Mean power (d = 0.29)
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Subjects

12 recreationallytrained males

19 recreationallyactive males and
females

12 resistance-trained
male NCAA Division
III football players

31 recreationallyactive males and
females

13 recreationallytrained males

Study

Spradley et al.
2012

Jacobs 2014

Jagim et al.
2016

Magrini et al.
2016

Martinez et al.
2016

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, parallel
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Design

Prop. Blend 1: (3500 mg)
β-alanine (2000 mg)
L-Tyrosine
Prop. Blend 2: (2000 mg)
Creatine
Arginine
BCAAs
Prop. Blend 3: (1750 mg)
Choline Bitartrate

b

Prop. Blend: (350 mg)
Caffeine (158 mg)
L-Leucine
B-Phenylethylamine HCl
L-Valine
L-Isoleucine
N-Acetyl-L-Tyrosine
Yohimbine
5-hydroxytryptophan

c
BCAAs (6000 mg)
Citrulline Malate (6000 mg)
Creatine (2000 mg)
β –Alanine (2000 mg)
Betaine (1500 mg)
L-Tyrosine (1500 mg)
Taurine (1000 mg)
N-Acetyl L-Cysteine (600 mg)
Caffeine (300 mg)

Prop. Blend 1: (13,000 mg)
Brown rice extract
β-alanine
Agmatine sulfate
Grape seed extract
Caffeine

BCAAs (6000 mg)
Creatine (5000 mg)
β-alanine (4000 mg)
Citrulline malate (1500 mg)
Caffeine (300 mg)

b

Taurine, Glucoronolactone,
Caffeine
β-alanine (2500 mg)
Creatine (5000 mg)
Vitamin C (7900 mg)

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

Table 1 Performance outcomes in acute MIPS studies (Continued)

20 min prior to
exercise

30 min prior to
exercise

30 min prior to
exercise

20 min prior to
exercise

20 min prior to
exercise

Timing

Medicine Ball Put, VJ, BP
1RM, WAnT

Pushup RTF

CMVJ, 5 × 5 bench press at
85% 5RM, 1 set of RTF at
85% 5RM, Anaerobic
treadmill sprint test.

Maximum Bodyweight
Exercise Repetitions
Completed during a 20-min
Exercise Bout

LP and BP RTF Repeated 2
Times, Choice Reaction
Time Test Repeated 4
Times, Intermittent Critical
Velocity Test Repeated 4
Times

Performance Testing
Protocol

[37]

[40]

[5]

[34]

[41]

↑ Repetitions Completed (d = 0.33)

↑ BP RTF During Set 5 (d = 0.38)
↑ BP Total Volume Load (d = 0.19)
↑ Mean Sprint Power (d = 0.25)
↔ BS RTF
↔ BS Total Volume Load
↔ Lower Body Power

↔ Pushup RTF

↑ WAnT Peak Power (d = 0.30)
↑ WAnT Mean Power (d = 0.24)
↔ MBP Performance
↔ VJ
↔ BP 1RM

Ref #

↑ LP RTF (T1: d = 0.42; T2: d = 0.72)
↑ Choice Reaction Time (Audio
Single Step: d = − 0.47; 15 s
Multi-Directional: d = − 0.46; 30s
Multi-Directional: d = − 0.33)
↔ BP RTF
↔ Critical Velocity
↔ Anaerobic Running Capacity

Results (d or RE)
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Subjects

25 recreationallyactive males and
females

25 recreationallyactive males and
females

21 resistance-trained
males and females

12 resistance-trained
males

Study

Collins et al.
2017

Jung et al.
2017

Tinsley et al.
2017

Bergstrom et
al. 2018

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Design

30 min prior to
exercise.

30 min prior to
exercise.

Citrulline Malate (6000 mg)
L-Leucine (4000 mg)
D-Aspartic Acid (3000 mg)
Creatine (2000 mg)
β-alanine (1600 mg)

60 min prior to
exercise.

30 min prior to
exercise.

Timing

Supplement 1:
Creatine (3000 mg)
Betaine (2500 mg)
L-Carnitine L-Tartrate
(1000 mg)
Rhodiola rosea extract
(180 mg)
Huperzine (200 mcg)
c
Supplement 2:
BCAAs (6000 mg)
Citrulline Malate (6000 mg)
Creatine (2000 mg)
β –Alanine (2000 mg)
Betaine (1500 mg)
L-Tyrosine (1500 mg)
Taurine (1000 mg)
N-Acetyl L-Cysteine (600 mg)
Caffeine (300 mg)

Supplement 1:
β-alanine (3000 mg)
Creatine (2000 mg)
L-arginine (2000 mg)
N-Acetyl-L-tyrosine (300 mg)
Caffeine (284 mg)
Mucana pruitiens extract
(15 mg)
Supplement 2:
Supplement 1 + Citrus
aurantium extract (20 mg)

β-alanine (2100 mg)
Arginine nitrate (1300 mg)
Folic acid (325 mcg)
Caffeine (200 mg)
Niacin (65 mg)
Vitamin B12 (45 mcg)

Glucuronolactone
Caffeine

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

Table 1 Performance outcomes in acute MIPS studies (Continued)

8 resistance exercises, 4 sets
of RTF at 75% 1RM
followed by:
Isokinetic MVC, VJ, Bench
Throw, Cycle Critical Power

Isokinetic squat MVC, 4 × 6
isokinetic squats

2 × 10 BP and LP at 70%
1RM, BP and LP RTF at 70%
1RM, WAnT, Stroop Test

BP and LP 1RM,
2 × 10 BP and LP at 70%
1RM,
BP and LP RTF at 70% 1RM,
4 km cycle TT

Performance Testing
Protocol

[23]

[39]

[32]

[33]

Supplement 2: ↑ Resting Metabolic
Rate (d = 0.71)
↑ Respiratory Exchange Ratio
(d = 1.14–1.66)
↑ Stroop Test Performance
(d = 0.36–0.69)
↔ BP RTF
↔ LP RTF
↔ WAnT Power

↔ Squat MVC

↑ Total Exercise Volume (d = 0.42)
↑ Lower Body Exercise Volume
(d = 0.57)
↔ Upper-body Exercise Volume
↔ Isokinetic MVC

Ref #

↑ BP RTF (d = 0.57)
↑ LP RTF (d = 0.55)
↑ BP Volume (d = 0.34)
↑ Total Lifting Volume (d = 0.50)
↑ Retention of LP Force
Production (NA)
↔ Retention of BP Force
Production
↔ TT Performance
↔ LP Volume

Results (d or RE)
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Subjects

15 recreationallyactive females

12 aerobically-trained
females

14 recreationallyactive males

23 recreationallyactive males

20 aerobically-trained
males and females

Study

Cameron et al.
2018

Erickson et al.
2018

Hahn et al.
2018

Lane et al.
2018

Musgjerd et al.
2018

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Randomized, Doubleblind, placebocontrolled, crossover
design.

Design

Prop. Blend 1: (1000 mg)
L-Carnitine
Green Coffee Bean Extract
Cayenne Fruit Extract
Forskolin
Prop. Blend 2: (371 mg)
N-Acetyl-L-Tyrosine

d

L-Citrulline DL-Malate
(3000 mg)
β-alanine (2000 mg)
BCAAs (1500 mg)
Creatine (1500 mg)
Caffeine (300 mg)
Vitamin B6 (20 mg)
Vitamin B12 (500 mcg)

L-Tyrosine (500 mg)
Taurine (200 mg)
Caffeine (120 mg)
L-Carnitine (10 mg)
Vitamin B6 (15 mg)
Vitamin B12 (45 mcg)

Prop. Blend 1: (1000 mg)
L-Carnitine
Green Coffee Bean Extract
Cayenne Fruit Extract
Forskolin
Prop. Blend 2: (371 mg)
N-Acetyl-L-Tyrosine
Caffeine (150 mg)
Mucana pruitiens extract
(15 mg)
β-alanine (1600 mg)
Arginine (1000 mg)

d

Prop Blend: (5850 mg)
β-alanine
Choline Bitartrate
L-Tyrosine
L-Glycine
Taurine
L-Carnitine
Betaine
Hawthorn Berry
Agmatine Sulfate
Caffeine

L-Tyrosine (1200 mg)
Caffeine (350 mg)

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

Table 1 Performance outcomes in acute MIPS studies (Continued)

30 min prior to
exercise

20 min prior to
exercise.

20 min prior to
exercise.

30 min prior to
exercise.

60 min prior to
exercise.

Timing

Simulated 5 km running
race

CMVJ, Repeated Cycle
Sprint Test, 10 × 3 bench
press at 80% 1RM

CMVJ, Treadmill Sprint Test

30 min constant velocity
treadmill running at 90% VT

BP and BS RTF at 85% 5RM,
CMVJ, Treadmill Sprint Test

and Anaerobic Capacity
Tests

Performance Testing
Protocol

[4]

[47]

[42]

[6]

[45]

↔ Fat oxidation

↔ Average Power
↔ Peak Power

↑ Bench Press Peak Velocity
(d = 0.83)
↑ Bench Press Mean Velocity
(d = 0.86)
↔ Cycle Sprint Power
↔ CMVJ

↔ Running performance

Ref #

↑ Bench Press RTF (RE = 107.66)
↑ Total Work during Sprint
(d = 0.14)
↑ Resting Metabolic Rate (d = 1.64)
↔ Back Squat RTF
↔ CMVJ

↔ Bench Throw
↔ Critical Power

Results (d or RE)
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Subjects

Design

Caffeine (150 mg)
Mucana pruitiens extract
(15 mg)
β-alanine (1600 mg)
Arginine (1000 mg)

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

Timing

Performance Testing
Protocol

Results (d or RE)

Ref #

↑ = MIPS was significantly greater (p < 0.05) than control; ↓ = MIPS was significantly less (p < 0.05) than control; ↔ = No significant difference (p > 0.05) was observed between MIPS and control; 1RM 1 repetition maximum,
BP Bench press, BS Back Squat, CMVJ Countermovement vertical jump, d Effect Size, km kilometer, LP Leg press, MBP Medicine ball put, mg milligram, mcg microgram, MVC Maximal voluntary contraction, RE Relative Effects,
RTF repetitions to fatigue, VO2max maximal oxygen consumption, VJ Vertical jump, VT Ventilatory threshold, TT Time trial, TTE time to exhaustion, WAnT Wingate anaerobic cycle test
a
Studies used an identical MIPS containing BCAAs, β-alanine, caffeine, and creatine
b
Studies used similar formulations of a MIPS containing BCAAs, β-alanine, caffeine, creatine, and citrulline malate
c
Studies used an identical MIPS containing BCAAs, β-alanine, caffeine, creatine, citrulline malate, betaine, and tyrosine
d
Studies used an identical MIPS containing β-alanine, caffeine, L-arginine, L-tyrosine and Mucana pruitiens extract (15% L-Dopa)

Study

Table 1 Performance outcomes in acute MIPS studies (Continued)
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to fatigue compared to placebo (RE = 107.66,
p = 0.037), though no between-group differences were
observed for back squat repetitions to fatigue. Likewise, Jagim et al. [5] noted that male participants performed significantly more bench press (d = 0.38,
p = 0.027, small) but not back squat repetitions to fatigue compared to placebo after consuming MIPS.
Conversely, Spradley and colleagues [37] reported that
a pre-workout supplement significantly improved leg
press but not bench press repetitions to fatigue at
75% 1RM (d = 0.42–0.72, p < 0.024, small - moderate). However, Collins and associates [23], observed
that acute MIPS consumption significantly increased
both bench press (d = 0.57, p < 0.05, moderate) and
back squat (d = 0.55, p < 0.05, moderate) repetitions to fatigue at 70% 1RM compared to pre-supplementation
values. Such an increase is particularly notable, since
the participants were able to improve upon
pre-testing values even after fatiguing exercise. Thus,
while mixed results have been reported, the consensus
is that consumption of MIPS may significantly augment muscular endurance performance as measured
by repetitions to fatigue.
Similarly, acute MIPS usage appears to augment the
total exercise volume completed by participants in a variety of open-ended exercise modalities where maximal
performance is encouraged. Jagim et al. [5] reported that
acute MIPS ingestion significantly increased total volume load completed by participants (defined as total
repetitions completed x load) during a bench press set
to fatigue at 85% of 5RM (d = 0.19, p = 0.032, very
weak), though no such effect was found for back squat
using an identical protocol. Likewise, Collins and colleagues [23] found that acute consumption of a
ready-to-drink MIPS prior to open-ended bench press
and leg press tests increased both bench press volume
(d = 0.34, p < 0.05, small) and total lifting volume
(d = 0.50, p < 0.05, moderate) relative to fat-free mass
completed by the participants. These results were supported by Gonzalez et al. [38], who noted that total lifting volume completed during four sets of barbell back
squat or bench press at 80% 1RM was significantly augmented (d = 0.30, p = 0.022, small) following consumption of a MIPS 10 minutes prior to exercise. Bergstrom
and colleagues [33] likewise demonstrated that
pre-exercise consumption of a MIPS resulted in significantly greater total (d = 0.42, p = 0.004, small) and
lower-body volume load (d = 0.57, p = 0.010, moderate)
completed during a session consisting of four
lower-body and four upper-body multi-joint barbell exercises, with four sets to fatigue at 70% 1RM being performed for each exercise. However, the researchers
noted that upper-body volume was unchanged relative
to placebo.

Page 10 of 28

Conversely, Bloomer et al. [35] noted that both total
and mean volume load performed during 10 sets of repetitions to fatigue at 50% 1RM using a bench press machine were unaffected by MIPS consumption. Similarly,
Jung and associates [39] reported that the pre-exercise
consumption of a caffeine-containing MIPS both with
and without 20 mg synephrine had no effect on total lifting volume completed during bench press and leg press
repetition tests to fatigue at 70% 1RM. However, bench
press lifting volume tended to be greater during the
third set of the MIPS + synephrine condition. The effect
of MIPS consumption on total volume completed during
other open-ended exercise modalities has received less
attention, though several recent studies have reported
promising results. For example, Cameron et al. [4] found
that a caffeine-containing MIPS consumed 1 hour prior
to sprint running significantly increased the total distance covered during a 25 s maximal-effort sprint test
on a force-treadmill (d = 0.14, p = 0.039, very weak).
Likewise, Jacobs et al. [40] observed that MIPS supplementation resulted in significantly greater volume of
bodyweight exercise completed by male and female
participants during a 20-min timed high-intensity
bodyweight workout bout (d = 0.33, p < 0.05, small).
Power production

Conflicting results have been reported regarding the effect of MIPS on upper-body and lower-body power production, though preliminary evidence has suggested that
consumption of MIPS may help to retain upper-body
power production following exercise. Bergstrom and
colleagues [33] found that bench press throw barbell velocity assessed after a fatiguing bout of resistance exercise
was similar to baseline measures when subjects consumed MIPS pre-exercise, but was significantly decreased
(d = − 0.58, p < 0.05, moderate) following consumption of
placebo. Other investigations have assessed the effect of
MIPS supplementation on barbell velocity during resistance exercise, with mixed results. Gonzalez et al. [38] reported that consumption of MIPS resulted in increased
average peak (d = 0.53, p < 0.001, moderate) and mean
power performance (d = 0.29, p < 0.001, small) assessed
via a linear position transducer during four sets of
multi-joint exercise to fatigue. Lane and Byrd [6] investigated the effects of acute MIPS consumption in
recreationally-trained males and likewise found that acute
consumption of a MIPS as well as a caffeine-matched placebo resulted in increased peak velocity during bench
press exercise (d = 0.83–0.86, p < 0.046, large) compared
to placebo alone. Conversely, Jagim and associates [5]
found no treatment effect of MIPS on either peak and
average power measured with a linear position transducer
during six sets of Smith machine back squat and bench
press exercise. These results are in accordance with the
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findings of Bloomer and colleagues [35], who noted that
the consumption of three types of MIPS had no effect on
upper body power as measured by bench press throws at
30% 1RM. Martinez et al. [41] likewise failed to show a
treatment effect of acute MIPS consumption on performance during a medicine ball put test, which requires participants to throw a medicine ball as far as possible.
Pre-exercise MIPS consumption appears to improve
anaerobic sprinting performance in certain cases, though
results are inconclusive. Jagim and associates [5] observed significant increases in mean power production
(d = 0.25, p < 0.034, small) following MIPS ingestion
during a 25-s maximal effort sprint test on a non-motorized treadmill set to a resistance equal to 18% bodyweight. However, later investigations by the same
research group using similar treadmill testing protocols
found no between-group differences in either peak or
mean power production during the sprinting tests in
both male [42] and female [4] subjects following consumption of two different MIPS products. Spradley et al.
[37] likewise failed to show an effect of MIPS consumption on anaerobic running capacity as assessed by intermittent critical velocity testing. Conflicting results have
likewise been reported regarding the effect of MIPS on
anaerobic cycling performance. Martinez and associates
[41] reported that peak and mean power measured during a Wingate anaerobic test (30 s all-out cycling with a
resistance equal to 7.5% bodyweight) were significantly
increased (d = 0.24–0.30, p < 0.006, small) following consumption of MIPS. Conversely, Jung et al. [39] as well as
Hoffman et al. [36, 43] found no effect of acute MIPS
consumption on Wingate anaerobic cycling performance. Lane and Byrd [6] also failed to show an ergogenic
effect of MIPS or a caffeine-matched placebo on repeated 5 s Wingate cycling performance.
Similarly, it appears that MIPS ingestion has little effect on jumping performance, as three recent studies
conducted by the same research group found no treatment effect of MIPS on countermovement vertical jump
height or power production in male [5, 42] and female
[4] subjects following acute ingestion. These results
were also supported by Lane and Byrd [6], who found
no effect of acute MIPS supplementation on vertical
jump performance.
Endurance exercise performance

Limited evidence exists regarding the effect of acute
MIPS ingestion on endurance exercise performance. To
date, only one study has investigated the effect of acute
MIPS supplementation on time to exhaustion during endurance exercise, with promising results. Walsh and colleagues [44] utilized a randomized, double-blind, crossover
design to assess the effect of a caffeine-containing MIPS on
time to exhaustion during treadmill exercise performed at a
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customized velocity and grade that elicited 70% of each
subject’s VO2max. The researchers found that time to exhaustion was significantly greater following MIPS consumption compared to placebo, as subjects were able to
run 12.5% longer (NA) after consuming the supplement
10 min before exercise. However, a recent study by Collins
et al. [23] found that acute MIPS consumption had little effect on cycling time-trial performance in resistance-trained
males and females. Following a one-minute warmup with
gradually increasing load, participants performed a 4 km
time trial as quickly as possible using a standardized resistance of 4 J/kg/rev. No differences in time, wattage, or relative wattage were observed between conditions. However,
because participants completed the time trial faster after
consumption of MIPS compared to placebo, the researchers noted that the MIPS did not result in an ergolytic
effect on performance. Similarly, Musgjerd and colleagues
[45] noted that acute MIPS supplementation had no effect
on running performance during a simulated 5 km running
race. Clearly, more information is needed before results can
be generalized further.
Subjective responses

Acute MIPS ingestion appears to improve self-reported
subjective measures of focus, fatigue, alertness and
self-reported energy levels, though conflicting results
have been reported. Hoffman and colleagues [43] noted
that pre-exercise consumption of a caffeine-containing
supplement resulted in significantly increased subjective
feelings of energy (d = 0.8, p < 0.05, large) and focus
(d = 0.82, p < 0.05, large) as well as a trend towards increased alertness in male strength and power athletes
during testing sessions that included repeated Wingate
anaerobic cycle tests and reaction time testing. A 2010
study by the same research group [36] reported that
recreationally-active subjects who consumed a caffeinecontaining supplement prior to exhaustive exercise were
better able to maintain focus and alertness (NA) compared to those who consumed placebo, though fatigue
was elevated after exercise (NA) in the MIPS group but
not the placebo group. A later study by Jagim et al. [5]
using similar Likert-based subjective assessments found
that subjects who consumed a caffeine-containing MIPS
reported significantly lower subjective fatigue (d = −
3.78, p = 0.01, strong) and increased alertness (d = 2.72,
p < 0.05, strong) following high-volume resistance exercise to fatigue. In addition, subjects in the treatment
group reported significantly greater feelings of focus
following completion of maximal treadmill sprinting
(d = 2.78, p = 0.01, strong). A similar study by the same
research group [4] found that females who ingested a
caffeine-containing MIPS reported significantly greater
feelings of focus (NA) at 80 min after ingestion compared to placebo, though no effect was found on feelings
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of energy and fatigue. Likewise, Spradley and colleagues
[37] found that self-reported energy was higher
(d = 1.34, p < 0.05, strong) and fatigue significantly lower
(d = − 1.46, p < 0.05, strong) in recreationally-trained
males at the midpoint of the testing session, approximately 95 min after consumption of a MIPS. The researchers reported significant main effects of treatment
for self-reported energy (d = 0.35, p < 0.05, small), focus
(d = 0.71, p < 0.05, moderate), and alertness (d = 0.53,
p < 0.05, moderate) across the entire testing session,
which included resistance exercise and reaction time
drills. Similar results were observed by Walsh et al. [44],
who found that subjects who consumed MIPS reported
significantly greater feelings of focus (d = 0.54, p = 0.031,
moderate) and energy (d = 0.49, p = 0.016, small) and
less fatigue (d = 0.60, p = 0.005, moderate) immediately
before treadmill exercise as well as greater feelings of
focus (d = 0.67, p = 0.026, moderate) and energy
(d = 1.26, p = 0.004, strong) 10 minutes after the start of
a treadmill time to exhaustion protocol at 70% VO2max.
No between-group differences were found after completion of the exercise protocol. Jung and colleagues [39]
also observed that participants who consumed MIPS
with or without added synephrine reported they felt
more vigorous and energetic (d = 0.52, p < 0.05, moderate) and were more optimistic about their future performance (d = 0.26–0.32, p < 0.05, small) compared to
those who consumed placebo, though those who consumed MIPS with added synephrine reported significantly lower feelings of vigor and energy immediately
after testing (d = − 0.55, p < 0.05, moderate) compared
to participants who consumed placebo or MIPS alone.
Conversely, Hahn and colleagues [42] reported that
self-reported feelings of fatigue following maximal-effort
treadmill sprinting were significantly elevated after consumption of both MIPS (d = 1.16, p < 0.05, strong) and
placebo (d = 2.86, p < 0.05, strong), though the magnitude of the change from baseline was significantly lower
(d = − 1.10, p < 0.05, strong) in the MIPS condition compared to placebo. Additionally, Gonzalez et al. [38]
found no effect of MIPS on ratings of energy, fatigue, or
focus during a bout of multi-joint resistance exercise to
fatigue; findings which were replicated by Tinsley et al.
[32] who did not detect between-group differences in
any self-reported subjective variables during a bout of
isokinetic squat exercise. Finally, Musgjerd and colleagues [45] demonstrated that acute MIPS consumption
had no effect on subjective measures of fatigue, alertness,
energy, or focus either before or after a 5 km simulated
running competition. In contrast to other investigations
which examined self-reported mood state and fatigue,
Bloomer and colleagues [35] instructed subjects to rate
their perceived muscle “pump” before and after exercise.
The researchers defined “pump” as a feeling of size,
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hardness, and swelling within the muscle. While the subjects reported increased levels of “pump” after exercise, no
between-group differences were noted. There appears to
be a general trend regarding a positive influence on subjective ratings of energy and fatigue following MIPS ingestion, which could play a role in the overall quality of a
training session and improve exercise tolerability for certain individuals.
Reaction time and cognitive processing

The results of several investigations suggest that acute MIPS
consumption may have a beneficial effect on reaction time
in recreationally-trained [36, 37] and resistance-trained [43]
males. Hoffman and colleagues [43] investigated the acute
effects of a ready-to-drink caffeine-containing MIPS on reaction time performance during three tests which were interspersed with 20-s Wingate Anaerobic cycle tests. The
researchers found that MIPS resulted in significant improvements in the number of targets struck during the test
(d = 0.53, p < 0.05, moderate) as well as percent of targets
struck (d = 0.48, p < 0.05, small) relative to placebo. A similar investigation by the same group [36] found that recreationally-active participants who consumed MIPS were
better able to maintain reaction time (NA) after a bout of
exhaustive exercise compared to those who consumed
placebo. These results were supported by Spradley et al.
[37] in a later study, who found that acute MIPS consumption resulted in significantly improved reaction time
performance during a 30 s test (d = − 0.33 - -0.46,
p < 0.05, small) using combined visual and auditory stimuli. Furthermore, Jung and colleagues [39] found that
acute consumption of a MIPS with added synephrine significantly improved performance during a Stroop test
(d = 0.36–0.69, p < 0.037, small to moderate), a type of
standardized cognitive function test that measures reaction time, selective attention, and cognitive processing.
Thus, while more information is required in this area, initial results are promising.
Hormonal response to resistance exercise

The effect of acute MIPS consumption on the short-term
hormonal response to resistance exercise is unclear; as
mixed results have been reported in the literature.
Ratamess et al. [46] reported that MIPS consumed 20 min
before 6 sets of 10 repetitions of back squat exercise at
75% 1RM had no effect on serum levels of total testosterone and growth hormone (GH) in resistance-trained
males during 30 min of recovery. However, a later study
by the same research group [16] using a similar design
and population found that subjects who consumed the
same MIPS after 1 week of creatine loading had significant
improvements in post-exercise serum growth hormone
(NA), total testosterone (NA), and insulin levels (NA)
compared to those who consumed placebo after an
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identical creatine loading protocol. Clearly, more information is needed in this area.
Energy expenditure and substrate utilization

Acute MIPS consumption may affect energy expenditure
as well as substrate utilization at rest, though conflicting
results have been reported. Similarly, limited evidence
exists regarding the effect of MIPS on substrate
utilization during prolonged aerobic exercise. Cameron
and colleagues [4] reported that acute MIPS consumption resulted in higher resting energy expenditure (REE)
(d = 1.64, p < 0.043, large) in recreationally-active females. Conversely, Jung et al. [39] found that a MIPS
with added synephrine increased REE (d = 0.71, p < 0.05,
large) and RER (d = 1.14–1.66, p < 0.05, large) in
recreationally-active male and female participants relative to placebo during a supine resting metabolic rate
test. However, Erickson and colleagues [47] found no effect of acute MIPS consumption on fat oxidation in females during 30 min of treadmill running at 90%
ventilatory threshold. Clearly, more investigations in a
wider variety of populations are required before definite
conclusions can be determined regarding any metabolicrelated benefits.
Gender

Limited evidence exists regarding a gender effect of acute
MIPS supplementation, as none of the eight acute MIPS
studies which examined the effects of MIPS on a mixed
gender cohort [23, 32, 34, 36, 39, 40, 44, 45] reported any
form of menstrual control, and only two of these investigations [23, 32] used gender as a covariate in their analyses. Collins and colleagues [23] used gender and relative
caffeine intake as covariates in their analysis to control for
the influence of the menstrual cycle and birth control,
though they noted that no time x treatment x gender
interaction effects were found for any outcome variable.
Similarly, Tinsley et al. [32] did not detect any time x
treatment x gender interaction effects, suggesting that any
gender effect of MIPS supplementation is minimal. In
addition, two investigations [4, 47] have examined the effects of acute MIPS supplementation in female participants only. While both did not report any form of
menstrual control, the results of these studies are not particularly divergent from those conducted in males. Cameron et al. [4] found MIPS increased upper-body muscular
endurance but had no effect on lower-body muscular endurance or power production, while Erickson et al. [47]
reported that acute MIPS supplementation had no appreciable effect on rates of fat oxidation. However, any
conclusions regarding a gender effect of acute MIPS supplementation are likely premature until more robust studies that utilize menstrual control are conducted.
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Chronic effects of MIPS on performance
Many investigations have employed short-term (10 days
or less) as well as long-term (greater than 10 days) supplement interventions both with and without a concurrent training intervention. Studies including a training
intervention are termed ‘training studies,’ while those
that employed a single testing bout of exercise are
termed ‘supplement loading studies.’ Additionally, some
studies used protocols which incorporated MIPS ingestion on the day of post-testing. These studies and
their relevant supplementation protocols are outlined
in Tables 2 and 3.
Short-term supplementation (< 10 days)
Force production

At best, short-term MIPS consumption might preserve
1-RM performance after several bouts of fatiguing exercise but does not appear to favorably impact maximal
strength. For example, Collins et al. [23] performed a
6-day supplement loading study. During baseline testing,
participants completed 1RM and muscular endurance (3
sets of 10 repetitions, last set to fatigue) testing of the
bench and leg press before and after an acute dose of
MIPS or placebo. All participants were instructed to
consume MIPS for an additional 5 days, and on the sixth
day, participants performed identical post-testing. The
authors claim that placebo consumption resulted in significantly lower leg press 1-RM after exhaustive exercise,
while those who had consumed MIPS for 5 days retained
greater force production and thus had significantly
greater 1RM performance (d = 0.18, p = 0.3, very weak).
However, the combination of the large reported p-value
and small effect size suggest that there was no difference
between placebo and MIPS. Similarly, Outlaw et al. [48]
found no influence of MIPS on bench press or leg press
1RM relative to placebo following an 8 day supplementation protocol coupled with four resistance training bouts.
Given the minimal amount of research, it is difficult to
conclude that any marked benefit of short-term MIPS
supplement loading on force production is present.
Muscular endurance and total volume completed

Several studies have evaluated muscular endurance following a short-term supplement loading protocol, with
somewhat promising results. Collins et al. [23] claimed
that short term supplementation (5 days) with a MIPS
tended to significantly increase repetitions to failure on
the leg press compared to placebo (d = 0.455, p = 0.116,
moderate) and improve leg press lifting volume after exhaustive exercise (d = 0.24, p = 0.157, weak). Again, however, the large p-values suggest that these claims are not
evidenced by the results of this investigation. Similarly,
Kraemer et al. [49] found that 7 days of MIPS supplementation significantly improved Smith machine squat

9 resistance
trained males

20 resistance
trained males

25 resistance
trained males and
females

30 resistance
trained males

Kraemer et al.
2007

Outlaw et al.
2014

Collins et al.
2017

Martin et al.
2017

Double-blind, placebo
controlled,
supplementation study

Double-blind, placebo
controlled, 7-day
supplementation study

Double-blind, placebo
controlled, training
study

Double-blind, placebo
controlled, cross-over,
7-day supplementation
study

Design

Unreported time
point during
supplementation
phase

Unreported time
point during
supplementation
phase

β-alanine (2100 mg)
Arginine nitrate (1300 mg)
Folic acid (325 mcg)
Caffeine (200 mg)
Niacin (65 mg)
Vitamin B12 (45 mcg)
Creatine (2000 mg)
Β-alanine (1600 mg)
L-Citrulline (1000 mg)
Caffeine (300 mg)
L-Norvaline (200 mg)
L-Theanine (100 mg)
Whole coffee fruit extract
(100 mg)
Theacrine (50 mg)

30 min prior to
exercise or during
the morning
hours on off days

30 min prior to
exercise or at a
similar time on off
days

Timing

Prop. Blend: (8400 mg)
Creatine
β-alanine
BCAAs (4800 mg)
Caffeine (275 mg)

L-Arginine (2000 mg)
D-Ribose (1500 mg)
L-Carnitine (400 mg)
L-Citrulline (200 mg)
Betaine (100
mg)
Caffeine (70 mg)

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

NA

NA

8 days of
supplementation
with four split body
training sessions

NA

Training Protocol

Leg extension RTF at
30% or 80% 1RM1

BP and LP 1RM,
2 × 10 BP and LP at 70%
1RM,
BP and LP RTF at 70%
1RM, 4 km cycle TT1

DEXA, VJ, BP & LP 1RM,
WAnT1

CMVJ, six sets of BS RTF
at 80% 1RM, isometric
squat force1

Performance Testing
Protocol

[50]

↔ RTF
↔ Volume load

[48]

↔ Power
↔ Body Composition
↔ BP 1RM
↔ LP 1RM

[23]

[49]

↑ Power (NA)
↑ RTF for 5 of 6 sets
(d = 0.41–1.08)

↔ Retention of force
production
↔ Muscular endurance
↔ Lifting volume
↔ Power

Ref #

Results (d)

↑ = MIPS was significantly greater (p < 0.05) than control; ↓ = MIPS was significantly less (p < 0.05) than control; ↔ = No significant difference (p > 0.05) was observed between MIPS and control; 1RM 1 repetition
maximum, %BF body fat percentage, BP bench press, BS back squat, CMVJ counter-movement vertical jump, d Effect Size, DEXA dual x-ray energy absorptiometry, FFM fat-free mass, FM fat mass, LP Leg press, mg
milligram, mcg microgram, POMS Profile of Mood States, RE Relative Effects, RTF repetitions to fatigue, WAnT Wingate anaerobic cycle test, VJ vertical jump
1
Testing performed with acute MIPS supplementation

Subjects

Study

Table 2 Performance outcomes and training adaptations in short-term (7–10 days) MIPS studies
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Subjects

38 sedentary
males and females

19 recreationallyactive males and
females

18 non-resistance
trained males

20 resistance
trained males

Study

Stout et al.
2008

Hoffman et al.
2010

Shelmadine et
al. 2009

Schmitz et al.
2010

Double-blind
resistance training
study using
comparator control

Double-blind,
placebo controlled,
resistance training
study

Randomized, Doubleblind, placebocontrolled
supplementation study.

Double-blind,
placebo controlled,
resistance and
endurance training
study

Design

c
Prop. Blend 1:
Whey protein (7 g)
L-Leucine (4 g)
L-Isoleucine
L-Valine
Prop. Blend 2:
Creatine (4 g)
Prop. Blend 3:
Taurine
L-alanyl-L-glutamine
Magnesium glycyl
glutamine
*Comparator matched for
carbohydrate, whey, and
creatine

a
Prop. Blend 1: (5350 mg)
L-Leucine
L-nor-Valine
L-Valine
L-Isoleucine
Prop. Blend 2: (10,952 mg)
Methyl Hydroxy Chalcone
Polymer
Creatine
Arginine Glutamine
Ariginine
Citrulline Malate
Prop. Blend 3: (229 mg)
L-Tyrosine
Caffeine

Acetyl-L-carnitine (500 mg)
L-tyrosine (500 mg)
Α-glycerophosphocholine
(150 mg)
Choline bitartrate (125 mg)
Caffeine (60 mg)
Phosphatidylserine (50 mg)

Prop. Blend: (1810 mg)
Taurine
Guarana extract
Green tea leaf extract
Caffeine
Glucuronolactone
Ginger

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

Begin 10–15 min
prior to exercise and
complete before end
of session. No
supplement on off
days.

30 min prior to
exercise or
immediately upon
waking on off days3

10 min prior to
testing. Timing not
specified on off days.

15 min prior to
exercise or ad libitum
on off days

Timing

Table 3 Performance outcomes and training adaptations in long-term (> 10 day) MIPS studies

9 weeks of
periodized
resistance training
(4 sessions/week;
upper/lower body
split)

28-days of
resistance training
(4 sessions/week;
upper/lower body
split)

NA

10 weeks of
resistance and
endurance
training based on
ACSM guidelines

Training Protocol

DEXA, BP 1RM, 3 sets of
RTF at pretesting body
weight3

DEXA, muscle biopsies,
BP & LP 1RM3

Choice Reaction Time
Test before and after the
following:
WAnT, Maximum
Pushup Repetitions
Completed in one
Minute, Maximum Situp
Repetitions Completed
in one Minute1

Body composition,
VO2peak, TTE3

Performance Testing
Protocol
[62]

[36]

[53]

[51]

↓ FM (NA)
↑ VO2peak (NA)
↑ TTE (NA)

↔ Reaction Time
↔ Peak Power
↔ Mean Power
↔ Pushups Completed
↔ Sit-ups Completed

↑ FFM (d = 0.24)
↑ Relative BP 1RM
(d = 0.23)
↔ Relative LP 1RM

↑
↑
↓
↑

BP 1RM (RE = 106.5)
RTF (RE = 131.8)
FM (RE = 87.1)
FFM (RE = 102.1)

Ref #

Results (d or RE)
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Subjects

24 recreationally
trained males

19 non-resistance
trained males

24 resistance
trained males

Study

Smith et al.
2010

Spillane et al.
2011

Ormsbee et al.
2012

Double-blind,
placebo controlled,
resistance training
study

Double-blind,
placebo controlled,
resistance training
study

Single-blind, placebo
controlled, HIIT
training study

Design

Prop. Blend 1: (9660 mg)
Casein Protein
Whey Protein
BCAAs
L-arginine
Prop. Blend 2: (4890 mg)
Creatine
Citrulline Malate
Arginine
Prop. Blend 3: (3170 mg)
β-alanine
Creatine
Prop. Blend 4: (376 mg)
Caffeine
*Subjects also consumed a
post-workout supplement

b

Prop. Blend 1: (5350 mg)
L-Leucine
L-nor-Valine
L-Valine
L-Isoleucine
Prop. Blend 2: (10,952 mg)
Methyl Hydroxy Chalcone
Polymer
Creatine
Arginine Glutamine
Ariginine
Citrulline Malate
Prop. Blend 3: (229 mg)
L-Tyrosine
Caffeine
*Subjects also consumed a
post-workout supplement

a

Prop. Blend: (2100 mg)
Cordyceps sinensis
Arginine
Creatine
Citrulline
Taurine
Leucine
Valine
Isoleucine
Caffeine
Whey protein

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

15 min prior to
exercise (pre) and
immediately after
end of exercise
(post). Ad libitum on
off days (post).

30 min prior (pre)
and within 30 min of
end of exercise
(post). Immediately
upon waking on off
days (post).

30 min prior to
exercise/testing.
Nothing on off days.

Timing

6 weeks of split
resistance training
(3 sessions/week)

28 days of
resistance training
(4 sessions/week)

3 weeks of HIIT
interval training (3
sessions/week)

Training Protocol

Table 3 Performance outcomes and training adaptations in long-term (> 10 day) MIPS studies (Continued)

DEXA, BP & LP 1RM,
Isokinetic strength
testing, WAnT2

DEXA, BP & LP 1RM,
muscle biopsies3

BodPod, VO2max
followed by four sprints
to exhaustion1

Performance Testing
Protocol

Ref #

[63]

[54]

[55]

Results (d or RE)

↑ Training volume (NA)
↔ FFM
↔ VO2max, critical
velocity

↓ FM (d = − 0.08)
↑ FFM (d = 0.17)
↑ Myofibrillar protein
mass (d = 0.32)
↑ Upper (d = 0.57),
lower-body (d = 0.62)
relative strength

↑ FFM (d = 0.18)
↔ Peak power
↔ BP 1RM
↔ LP 1RM
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Subjects

16 resistance
trained males

20 resistance
trained males

24 resistance
trained males

43 resistance
trained males and
females

Study

Willems et al.
2012

Lowery et al.
2013

Ormsbee et al.
2013

Kedia et al.
2014

Double-blind
resistance training
study using
comparator control

Double-blind,
Placebo-controlled,
resistance training
study

Double-blind,
placebo controlled,
resistance training
study

Double-blind,
placebo controlled,
training study

Design

Prop. Blend 1: (4580 mg)
Creatine
Betaine
Citrulline
Dendrobium extract
Caffeine
*Comparator product
matched for energy and
caffeine content

Prop. Blend 1: (9660 mg)
Casein Protein
Whey Protein
BCAAs
L-arginine
Prop. Blend 2: (4890 mg)
Creatine
Citrulline Malate
Arginine
Prop. Blend 3: (3170 mg)
β-alanine
Creatine
Prop. Blend 4: (376 mg)
Caffeine
*Subjects also consumed a
post-workout supplement

b

Prop. Blend 1: (2800 mg)
Creatine
β-alanine
Prop. Blend 2: (1600 mg)
L-Taurine
BCAAs
Alanyl-glutamine
Prop. Blend 3: (620 mg)
Glucuronolactone
Caffeine
Prop. Blend 4: (500 mg)
Natural nitrates
Quercetin (67 mg)

Whey protein (30 g)
Creatine (5.1 g)
Glutamine (5.1 g)
HMB (1.5 g)

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

30 min prior to
exercise and with
breakfast on off days.

15 min prior (pre)
and immediately
after exercise (post).
Ad libitum on off
days (post).

30 min prior and 3
servings throughout
the day on off days.

One dose in the
morning and another
within 15 min of
exercise end. Similar
time on off days.

Timing

6 weeks of
periodized
resistance training
(4 sessions/week;
upper/lower body
split)

6 weeks of
periodized
resistance training
(3 sessions/week)

8 weeks of split
focused resistance
training
(3sessions/week)

2, 6-week blocks
of progressive resistance training
(4 sessions/week)

Training Protocol

Table 3 Performance outcomes and training adaptations in long-term (> 10 day) MIPS studies (Continued)

DEXA, BP 1RM, VAS of
energy & concentration3

DEXA, POMS3

DEXA, BP & LP 1RM,
ultrasonography3

BP, LP, & lateral pull 1RM and RTF at 80%
1RM, peak isokinetic
torque measured via a
dynamometer, MVC3

Performance Testing
Protocol

Ref #

[58]

[52]

[65]

[3]

Results (d or RE)

↑ BP RTF* (d = 1.2)
↑ Lateral pull RTF*
(d = 1.3)
↔ 1RM*
↔ MVC, peak
concentric strength*
↑ FFM (RE = 104.1)
↑ Quadriceps muscle
thickness (RE = 108.0)
↑ BP 1RM (NA)
↔ LP 1RM

↑ FFM (d = 0.22)
↔ FM
↔ POMS

↑ Energy &
concentration (NA)
↔ FFM
↔ FM
↔ BP 1RM
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Subjects

17 recreationally
trained males

24 resistance
trained males

27 resistance
trained males

20 trained male
runners

Study

Kendall et al.
2014

Spillane et al.
2014

Kreipke et al.
2015

Ormsbee et al.
2015

Double-blind,
placebo controlled,
4-week supplementation study

Double-blind,
placebo controlled,
resistance training
study

Double-blind,
resistance training
study using
comparator control

Double-blind, placebo
controlled 4-week
supplementation
study

Design

Prop. Blend 1: (9660 mg)
Casein Protein
Whey Protein
BCAAs
L-arginine
Prop. Blend 2: (4890 mg)
Creatine
Citrulline Malate
Arginine
Prop. Blend 3: (3170 mg)
β -alanine
Creatine
Prop. Blend 4: (376 mg)
Caffeine

b

BCAA (2500 mg)
β-alanine (1020 mg)
Long jack root (250 mg)

c
Prop. Blend 1:
Whey protein (7 g)
L-Leucine (4 g)
L-Isoleucine
L-Valine
Prop. Blend 2:
Creatine (4 g)
Prop. Blend 3:
Taurine
L-alanyl-L-glutamine
Magnesium glycyl
glutamine
*Comparator matched for
maltodextrose, whey
protein, and creatine
monohydrate

BCAAs (6 g)
Creatine (5 g)
β-alanine (4 g)
Citrulline (1.5 g)
Caffeine (300 mg)

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

30 min prior to
exercise or
immediately upon
waking on off days.

20 min prior and 2 h
after exercise. With
breakfast and lunch
on off days.

½ dose consumed
15 min prior to
exercise, other ½
dose consumed at
start of exercise.
Nothing on off days.

20 min prior to
exercise and ad
libitum on off days.

Timing

NA

4 weeks of
progressive
resistance training
(4 sessions/week)

6 weeks of
periodized
resistance training
(4 sessions/week;
upper/lower split)

NA

Training Protocol

Table 3 Performance outcomes and training adaptations in long-term (> 10 day) MIPS studies (Continued)

Skinfolds, perceived
soreness VAS, ROM,
vertical jump, isokinetic
and isometric strength
using isokinetic
dynamometer, VO2max,
before and after a single
bout of downhill
running1

DEXA, squat, BP,
deadlight 1RM, POMS3

DEXA, BP, LP, & knee
extension 1RM, BP & LP
RTF at 75% 1-RM,
muscle biopsies3

Skinfolds (Brozek
equation), VO2max, BP &
LP 1-RM, RTF at 75%
1RM3

Performance Testing
Protocol

Ref #

[57]

[61]

[59]

[56]

Results (d or RE)

↑ VT (% of VO2max)
(d = 1.21)
↑ LP 1RM (d = 0.45)
↓ Relative VO2max
(d = − 0.52)
↔ Body Composition
↔ 1RM
↔ RTF

↑ BP 1RM (d = 0.05)
↑ Total weight lifted
(d = 0.15)
↑ Relative deadlift
strength (FFM:
d = 0.11; Total Mass:
d = 0.08)
↔ Isometric and
isokinetic strength
↔ Flexibility
↔ Power
↔ Perceived soreness
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8 trained female
runners

80 resistance
trained males

19 recreationally
active females

Köhne et al.
2016

Jung et al.
2017

Zabriskie et al.
2017

Double blind,
placebo controlled,
resistance training
study

Double-blind,
placebo controlled,
resistance training
study

Double-blind, placebo
controlled, 28-day
supplementation
study

Design

Prop. Blend 1: (5700 mg)
β-alanine
L-tyrosine
L-glycine
L-carnitine
Beet root
Hawthorn berry powder
Caffeine

Supplement 1:
β-alanine (3000 mg)
Creatine (2000 mg)
L-arginine (2000 mg)
N-Acetyl-L-tyrosine
(300 mg)
Caffeine (284 mg)
Mucana pruitiens extract
(15 mg)
Supplement 2:
Supplement 1 + Citrus
aurantium extract (20 mg)

Prop. Blend 1: (9660 mg)
Casein Protein
Whey Protein
BCAAs
L-arginine
Prop. Blend 2: (4890 mg)
Creatine
Citrulline Malate
Arginine
Prop. Blend 3: (3170 mg)
β-alanine
Creatine
Prop. Blend 4: (376 mg)
Caffeine
*Subjects also consumed a
post-workout supplement

b

Supplement Ingredients
(Sorted by order listed on
Supplement Facts label)

30 min prior to
exercise or after
breakfast on off days.

15–30 min prior to
exercise or with
breakfast on off days.

30 min prior to
exercise or
immediately upon
waking on off days.

Timing

7 weeks of
periodized
resistance training

8 weeks of
resistance training
(4 sessions/week;
upper/lower body
split)

NA

Training Protocol

[64]

[60]

[66]

↔ Hamstring flexibility
↔ Squat jump power
↔ Limb circumference

↔ 1RM leg & bench
press
↔ Power
↔ Readiness to
perform
↑ Stroop Test
Performance (d = 0.12–
0.16)

↔ FM
↔ FFM
↔ RMR

Cognitive function,
readiness to perform, BP
& LP 1RM, Wingate
anaerobic cycling test3

BodPod, RMR2

VO2max (before and after
supplementation),
muscle pain perception,
muscle damage markers,
squat jump power,
hamstring flexibility, and
limb circumferences
(before and after a
single bout of downhill
running after 28 days of
supplementation)1

Ref #

Results (d or RE)

Performance Testing
Protocol

↑ = MIPS was significantly greater (p < 0.05) than control; ↓ = MIPS was significantly less (p < 0.05) than control; ↔ = No significant difference (p > 0.05) was observed between MIPS and control; 1RM 1 repetition maximum,
%BF body fat percentage, BP Bench press, d Effect Size, DEXA dual x-ray energy absorptiometry, FFM fat-free mass, FM fat mass, RE Relative Effects, RTF repetitions to fatigue, LP Leg press, mg milligram, mcg microgram, POMS
Profile of Mood States, ROM range of motion, TTE time to exhaustion, VO2max maximal oxygen consumption, VT Ventilatory Threshold, WAnT Wingate anaerobic cycle test
a
Studies used an identical MIPS containing whey protein, caffeine, BCAAs, creatine, β-alanine, and L-arginine
b
Studies used a later formulation of the same brand name MIPS as a containing whey protein, caffeine, BCAAs, creatine, β-alanine, and L-arginine
c
Studies used an identical MIPS containing carbohydrate, whey, creatine, BCAAs and L-taurine
1
Testing performed with acute MIPS supplementation
2
Testing performed without acute MIPS supplementation
3
Presence of MIPS during testing not explicitly reported
*analysis performed using Cohen’s d effect sizes

Subjects

Study

Table 3 Performance outcomes and training adaptations in long-term (> 10 day) MIPS studies (Continued)
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repetitions to fatigue during 6 sets at 80% 1RM
(d = 0.41–1.08, p < 0.05, moderate - strong). However,
Martin and colleagues [50] found no effect of short-term
MIPS supplementation on total repetitions or volume
load completed during four sets of bilateral leg extensions to fatigue at both 30% and 80% 1RM. Again, given
the minimal volume of research in this area, no solid
conclusions can be made at this point in time.
Power production

A paucity of evidence exists regarding the effect of
short-term MIPS supplementation on power production.
Additionally, broad differences in study design make
comparisons between the conclusions of relevant studies
difficult. Kraemer and associates [49] found that individuals who had consumed MIPS for 7 days exhibited
higher vertical jump power output than individuals consuming placebo (NA). These results may suggest that
brief supplement loading may enhance performance during a single exercise bout. However, these findings contrast with those of Outlaw et al. [48], who found no
difference in peak anaerobic power production during a
30-s Wingate Anaerobic Cycle test between subjects
who consumed MIPS or placebo for 8 days. Collins et al.
[23] similarly found no difference in anaerobic power
output during a 4 km time trial in participants who had
consumed MIPS for 5 days compared to placebo consumers. The difference in testing paradigms may potentially explain some of the discrepancy in findings, as the
vertical jump depends largely on the ATP/PCr energy
system, while a Wingate test draws upon both anaerobic
energy systems. Clearly, more research is needed to investigate the effect of short-term MIPS supplementation
on power production.
Serum hormones and markers of muscle damage

Limited evidence exists regarding the effect of short-term
MIPS consumption on hormones or markers of muscle
damage caused by acute exercise. Kraemer et al. [49]
found no difference in lactate, glucose or insulin between
MIPS or placebo users after 7 days of supplementation.
However, serum levels of creatine kinase were significantly
lower midway through squat exercise (d = − 0.85, p < 0.05,
strong), immediately after exercise(d = − 0.76, p < 0.05,
moderate), and during 15 min of recovery (d = − 0.61,
p < 0.05, moderate), while myoglobin was reduced immediately following exercise (d = − 0.82, p < 0.05, strong) in
MIPS users relative to placebo, potentially suggesting that
the supplement may have affected muscle damage.
Kraemer and colleagues [49] also found that MIPS consumption resulted in greater increases in GH (NA) and
free testosterone (NA) midway during six sets of squats
performed to fatigue at 80% 1RM and during 15 min of
recovery (NA). Likewise, IGF-1 was elevated in the
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treatment group immediately before exercise (i.e. about
30 min after acute supplement ingestion) (NA), though insulin was no different between MIPS and placebo.
Gender

The only study included in this review which studied a
female population consuming a MIPS for a short period
of time is the investigation by Collins and colleagues
[23]. Roughly half of their total sample size was female
and gender was used as a covariate in their analysis.
Though expected differences in variables such as height,
body composition, absolute upper and lower body
strength, and relative upper body strength were noted,
researchers did not find the MIPS to exert a different effect on females than males over time. However, more research utilizing hormonal control is needed to fully
understand the effects of gender on MIPS.
Long-term supplementation (> 10 days)

A significantly greater volume of research exists that has
investigated the benefits of MIPS supplementation lasting more than 10 days, typically in conjunction with
some form of an exercise program. However, it is vital to
note that not all of these investigations are placebo-controlled, as several studies opted to provide a comparator
product lacking a proprietary blend of ingredients withheld by the supplement manufacturers as a control condition. However, these studies do not circumvent the
central issue of differing proprietary blends and formulations in the various MIPS that were investigated, making
it difficult to compare between products or identify primary active ingredients.
Force production

A substantial body of evidence suggests that long-term
consumption of MIPS positively influences force production. It appears that long-term MIPS ingestion paired
with resistance training results in increased 1-RM bench
press strength compared to training alone in both
trained (RE = 104.1–106.5, p < 0.02) [51, 52] and untrained [53, 54] males (d = 0.23–0.63, p < 0.05, weak moderate). It is worth noting that both of the studies
that found improvements in untrained males examined
the same pre-workout supplement (containing a proprietary blend of caffeine, whey, BCAAs, creatine, β-alanine,
and L-arginine) with a placebo control. However, one of
the studies also required participants to consume a
post-workout protein supplement, the addition of which
may potentiate training adaptations beyond MIPS alone
[54]. Regardless, these results suggest that chronic MIPS
ingestion either with or without post-exercise protein will
potentiate training adaptations resulting from a resistance
exercise program. However, another investigator found no
benefit of an identical MIPS on strength outcomes in
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resistance-trained males [55] or aerobically-trained males
[56]. Notably, the resistance trained males consuming this
specific MIPS also consumed a post-workout protein supplement, which also likely influenced training adaptations.
Interestingly, MIPS ingestion may improve upper-body
strength but not lower-body strength despite lower-body
resistance training, as evidenced by the work of
Shelmadine et al. [53] and Lowery et al. [52], who
both noted increases in bench press 1-RM but not leg
press 1-RM in both trained and untrained males. Kendall
et al. [57] likewise noted increases in leg press but not
bench press strength after 4 weeks of supplementation
loading without a supervised training intervention. However, due to the lack of supervised resistance training and
the high volume of aerobic exercise conducted by the participants, these results are less generalizable and should be
interpreted with caution. Conversely, Willems and associates [58] reported that MIPS supplementation resulted in
no significant increases in upper or lower-body strength
compared to placebo, though effect size analysis suggested
that strength may have been increased in muscle groups
and movements that were targeted during the resistance
training regimen (d = 0.98–1.41, p = 0.07, strong). These
results, though inconclusive, suggest that MIPS supplementation may support training-specific adaptations but
does not result in systemic increases in muscle strength.
Several unique ingredients not common to all MIPS
warrant mention. Kreipke et al. [59] found that resistancetrained participants who consumed a supplement containing long jack root had greater gains in bench press
strength relative to placebo (d = 0.05, p = 0.001, very
weak). The treatment group also improved deadlift 1RM
relative to body mass and lean mass. Another group utilizing a product that has since been discontinued due to
containing traces of a methamphetamine derivative [3]
found no benefit of added betaine, citrulline, or dendrobium extract compared to placebo on strength-related
outcomes. Likewise, Jung and associates [60] found no effect of chronic consumption of a MIPS containing
Mucana pruitiens extract (15% L-Dopa) or the same supplement with the addition of synephrine on 1RM bench
press when compared to placebo.
Muscular endurance

Limited research has examined the effect of chronic
MIPS ingestion on muscular endurance, and the results
are challenging to interpret as some studies are comparator controlled, while others are placebo controlled.
Several studies conducted in resistance-trained participants utilizing whole-body training regimens reported
beneficial results of MIPS relative to a comparator or
placebo [51, 58]. Schmitz and colleagues [51] found that
subjects who consumed MIPS containing a proprietary
blend of ingredients performed more bodyweight bench
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press RTF compared to those who consumed a creatine,
carbohydrate and protein-matched comparator (RE = 131.8,
p = 0.004). Similarly, results reported by Willems et al. [58]
suggest that repetitions to fatigue were enhanced at 80%
pre-intervention 1-RM in participants who consumed a
MIPS relative to those who consumed placebo (d = 1.2–1.3,
p < 0.05, strong). Conversely, several studies found no effect
of long-term MIPS consumption on muscular endurance.
Spillane et al. [61] investigated the effect of the same
supplement used by Schmitz et al. [51] and found no differences in RTF between those who consumed the experimental supplement relative to a comparator product. However,
these differences may be due in part to differences between
training interventions, as the program implemented by
Spillane and colleagues [61] was shorter (6 weeks vs.
9 weeks) than that used in the experiment by Schmitz et al.
[51]. Similarly, Hoffman et al. [36] found no effect of
chronic MIPS supplementation on maximum pushups or
sit-ups completed during a minute.
Power production

Preliminary evidence suggests that long-term MIPS supplementation may not augment lower-body power production. Ormsbee et al. [55] reported that trained males
consuming both MIPS and placebo who participated in
resistance training 3 days per week for 6 weeks experienced significant improvements in peak anaerobic power
during a Wingate test. Post hoc testing identified MIPS
users as having significantly increased their peak power
while placebo users remained unchanged. However,
these results must be interpreted with caution, as no statistically significant interaction (i.e. group x time) was
identified (p > 0.05). Hoffman and colleagues [36] likewise found no effect of 4 weeks of MIPS supplementation on either peak or mean power measured during a
Wingate test. Though evidence seems to indicate that
MIPS does not affect power production, more research
is needed to verify this hypothesis.
Endurance exercise performance

Limited research exists investigating aerobic performance following long-term MIPS ingestion, and results of
these studies are contradictory. Stout and colleagues
[62] found that peak oxygen consumption (VO2peak) and
time to exhaustion during a graded cycling exercise test
significantly increased by 8.4% and 5.7%, respectively,
among sedentary men and women who consumed a
MIPS containing caffeine, green tea extract, and glucuronolactone but not in those who consumed placebo during a 10-week resistance and aerobic exercise regimen
(NA). However, Smith et al. [63] found no between-group
differences in maximal oxygen consumption (VO2max)
after 3 weeks of HIIT training in recreationally-trained
males who consumed MIPS or placebo. Surprisingly,
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Kendall et al. [57] found that 4 weeks of supplementation
with a MIPS containing caffeine, creatine, and β-alanine
in recreationally-trained males resulted in decreased relative VO2max, though no such change was found in those
who consumed a placebo (d = − 0.51, p < 0.05, moderate).
However, the percent of VO2max at which ventilatory
threshold occurred significantly increased in the treatment
but not placebo group (d = 1.21, p < 0.05, strong). The
contrasting results offered by Kendall and colleagues may
be explained by the lack of a specific training intervention,
as all participants reported physical activity levels via
questionnaire. However, given the body of research it appears that long-term MIPS consumption may augment
aerobic performance in sedentary individuals beginning an
exercise program or among aerobically fit individuals beginning a high-intensity protocol. However, more research
is needed in this area.
Muscle damage

Early evidence suggests that long-term MIPS consumption has little effect on soreness, inflammation, and biomarkers of muscle damage resulting from exercise.
Ormsbee et al. [56] found no effect of 4 weeks of MIPS
consumption on perceived soreness, post-damage muscle
function, or biochemical measures of muscle damage in
endurance-trained males who performed a damaging
downhill running bout. These results were mirrored in a
trained female population by Köhne et al. [64], who reported that participants who consumed MIPS for 28 days
prior to and 3 days after a bout of downhill running had
no significant changes in soreness, muscle function, biomarkers of muscle damage, or inflammation, though effect
size analysis suggested that MIPS slightly attenuated
the inflammatory response to exercise. Clearly, more
information is required, though initial results do not
appear promising.
Body composition

The effect of MIPS on body composition appears to be
promising, though differences in study design and the
reliance on self-reported dietary intake make conclusions challenging. Several studies have found that the
long-term consumption of MIPS in resistance trained
males leads to greater increases in fat-free mass (FFM)
following six [55, 65] (d = 0.18–0.22, p < 0.05, weak) or 8
weeks [52] (RE = 104.1, p < 0.01) of resistance training
(three sessions per week) compared to a placebo. While
the aforementioned investigations used the same brand
of MIPS, participants also consumed a protein-based
post-workout supplement during each of the six-week
interventions, thus potentially confounding the conclusions regarding the isolated effect of MIPS supplementation that can be drawn from these studies. Chronic MIPS
consumption has also been shown to improve body
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composition in untrained populations, as Shelmadine et
al. [53] (d = 0.24, p = 0.001, weak) and Spillane et al. [54]
(d = 0.17, p = 0.023, weak) noted greater gains in FFM
after 28 days of resistance training in non-resistance
trained males consuming MIPS compared to placebo.
Additionally, Spillane and colleagues found a significantly
greater decrease in fat mass (FM) in the treatment group
(d = − 0.08, p = 0.026, very weak), though these effects
may be due in part to post-exercise protein ingestion in
addition to any chronic effect of MIPS supplementation.
Stout and coworkers [62] examined the effect of MIPS ingestion on body composition in sedentary men and
women during a 10-week resistance and endurance
training program and found that MIPS users lost significantly more FM (NA) relative to placebo users at
the end of the intervention. Interestingly, the MIPS
formulation employed in this investigation was the
only supplement to result in positive changes in body
composition that did not contain creatine.
Few placebo-controlled studies have found MIPS to
have no influence on body composition. Jung et al. [60]
examined the effects of a MIPS containing Mucana
pruitiens extract (15% L-Dopa), an identical MIPS with
added synephrine, or a placebo in 80 resistance-trained
males and found no effect of either MIPS formulation
on body composition relative to placebo after four or 8
weeks of training. Smith et al. [63] also found no differences
in body composition between MIPS and placebo users after
3 weeks of high-intensity interval training. Similarly, one of
the only studies to exclusively use female subjects [66]
found no change in body composition in females who consumed MIPS while participating in 7 weeks of resistance
training. Thus, it seems that long-term supplementation of
MIPS that contain creatine, β-alanine, whey protein, or
BCAAs may exert a favorable effect on body composition
in males participating in resistance training.
Several comparator-controlled studies have investigated the effect of long-term MIPS consumption on
body composition, with contrasting results. Kedia et al.
[3] and Spillane et al. [61] both found no improvements
in body composition after 6 weeks of resistance training
and supplementation among resistance-trained individuals
assigned to consume MIPS as opposed to comparator
product. However, another study reported significantly increased FFM (RE = 102.1, p = 0.049) and decreased FM
(RE = 87.1, p = 0.023) after 9 weeks of resistance training
in resistance trained males who consumed a MIPS with a
proprietary blend of amino acids compared to subjects
who consumed a carbohydrate, whey, and creatinematched comparator [51]. It is important to note that the
MIPS formulation used by Kedia and colleagues [3] was
primarily focused on promoting energy, with the comparator matched for energy and caffeine, while the comparator products used by Spillane et al. [61] and Schmitz
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et al. [51] were matched for carbohydrate, whey, and creatine. The results of these studies support the idea that
creatine and protein are likely the primary ingredients
driving increases in fat-free mass accretion.
Skeletal muscle adaptations

Three studies have utilized muscle biopsy techniques to
identify changes in skeletal muscle after extended exposure to MIPS. Shelmadine and colleagues [53] found
MIPS to increase myofibrillar protein content (d = 1.78,
p = 0.014, strong), total DNA (d = 2.96, p = 0.041,
strong), as well as myogenic regulatory factors Myo-D
(NA) and MRF-4 (NA) relative to placebo. Similarly,
Spillane et al. [54] found MIPS to increase myofibrillar
protein content (d = 0.32, p = 0.049, weak) as well as
Myo-D (d = 0.51, p = 0.038, moderate) and MRF-4
(d = 1.37, p = 0.001, strong). In a later study, the same
research group observed increased total muscle creatine
and total muscle protein in both MIPS users and those
who consumed a protein, carbohydrate, and creatinematched comparator during 6 weeks of heavy resistance
training [61]. In summary, as all of these experiments
found beneficial effects of long-term supplementation of
MIPS that contained whey protein, creatine, and
BCAAs, these ingredients likely lead to favorable skeletal
muscle adaptations.
Subjective measures

Several long-term MIPS studies have utilized the profile
of mood states (POMS) assessment to measure psychological responses to MIPS exposure. Ormsbee et al. [65]
investigated the subjective effects of MIPS consumption
and found no between-groups differences in mood state,
as training led to increased vigor in both those who consumed MIPS or placebo. Similarly, Kreipke and colleagues [59] did not witness any between-group
differences in mood state, as an increase in anger was
found in both participants who consumed placebo and
participants who consumed a MIPS containing long jack
root. Kedia and coworkers [3] documented the only difference in subjective measures between MIPS and comparator users and reported that MIPS led to increased
energy and focus during endurance testing as well as significantly higher self-perceived energy, concentration,
and focus (NA). The MIPS group also reported reductions in self-perceived fatigue. However, the product utilized in this experiment was later recalled for containing
methamphetamine analogs, which may explain many of
the alterations in subjective measures. Hoffman et al.
[36] likewise reported that recreationally-active subjects who consumed MIPS for 4 weeks were able to
maintain focus after a bout of exhaustive exercise,
while those who consumed placebo experienced declines in focus (NA).
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Reaction time and cognitive processing

It appears that chronic MIPS supplementation has little
effect on reaction time, as Hoffman and colleagues [36]
found no effect of a caffeine-containing supplement on
reaction time after a bout of exhaustive exercise. Jung et
al. [60] found that those who consumed a MIPS containing caffeine, L-tyrosine, and L-Dopa (derived from
Mucana puritens extract) with or without synephrine
had better performance during a Stroop test (d = 0.12–
0.16, p < 0.05, very weak). However, as only a single
study using a unique ingredient has investigated cognitive functioning after more than 10 days of MIPS exposure, more research is needed to bolster any conclusion
drawn from these findings.
Hormonal response

The hormonal response to long-term MIPS use has only
been evaluated in resistance trained males. In several
resistance-training studies which used the same MIPS
formulation, no changes were found in cortisol [65], GH
[55], or insulin-like growth factor-1 (IGF-1) [55] relative
to placebo. A similar product containing whey, creatine,
BCAAs, and taurine also had little effect on insulin,
IGF-1, cortisol, or GH relative to placebo [61]. While
testosterone has been shown to increase following training among both MIPS and placebo users [55], no study
has yet demonstrated an effect of chronic MIPS supplementation on testosterone concentration relative to placebo. Furthermore, consumption of a MIPS containing
long jack root had no effect on bioavailable testosterone,
free testosterone, total testosterone, sex-hormone binding globulin, or estradiol compared to placebo [59].
Gender

Four long-term supplementation studies included in this
review examined the effects of MIPS on both males and
females, while an additional two investigations only examined female participants. Stout et al. [62] included 20
males and 18 females in their study but did not control
for menstrual cycle or assess the effect of gender on any
outcome variable. Similarly, Kedia and colleagues [3] enrolled men and women into their 6-week long study,
though the authors did not disclose the ratio of females
to males or assess gender as a covariate. However, the
researchers controlled for the menstrual cycle. The sample obtained by Hoffman et al. [36] was only 11% female
(2/19 total participants) and researchers did not control
for menstrual cycle or include gender in their analysis,
likely due to the discrepancies in sample size. Köhne and
colleagues [64] explored the effects of a MIPS on flexibility, muscle damage, and power in female runners who
performed a single bout of downhill running during the
mid-follicular phase following 28 days of supplementation. Though Köhne and colleagues did not find any
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differences between MIPS and placebo with regard to
any outcome measure, these results are very similar to a
study performed in men using a nearly identical study
design and the same supplement [56]. Another study
using only female participants found that MIPS did not
influence RMR or body composition when compared to
placebo [66], though menstrual control was not mentioned in the manuscript. No consensus can be drawn
from these data on the effect of gender on long-term
MIPS consumption. Future studies should simultaneously compare men and women following the same
training protocol and using the same supplement while
controlling for hormonal status in female participants.

Safety implications of MIPS use
To date, relevant literature suggests that the consumption of many MIPS appears to be relatively safe with
minimal reported adverse effects. However, most studies
examining the effects of MIPS ingestion are relatively
short (less than 8 weeks). Several studies have examined
the effects of chronic MIPS ingestion on heart rate,
blood pressure and several hematologic markers with
minimal adverse effects reported [3, 53, 57, 67]. These
effects of varying durations of MIPS use on
health-related outcomes are outlined below in their respective sections. It is vital to note that many studies
only report mean changes within the entire sample and
do not specify whether a few individuals exceeded normal ranges at any point during the testing period. This
reporting technique may mask adverse events if individual changes above normal ranges are not clearly reported in a manner similar to that employed by Jung
and colleagues [60]. Future investigations should employ
this approach to present a more comprehensive picture
of the effects of MIPS on various clinical markers of
safety. With that being said, as with many prescription
medications, short-term use often tends to be relatively
safe with few serious adverse effects. However, clinical
manifestations may take months or even years to become present. Therefore, longer-term data is needed to
determine potential adverse physiologic adaptations due
to chronic exposure to MIPS. Previous reviews by Eudy
et al. [27] and Maughan et al. [68] have comprehensively
outlined potential adverse effects of frequently used ingredients in various sports supplements including MIPS.
Concerns regarding safety of supplement use go far
beyond merely examining the ingredient list that declared on the supplement label, as several supplements
have been found to contain contaminants such as heavy
metals, potent stimulants, or various banned ingredients
[69–71]. Alarmingly, Geyer et al. [72] reported that up
to 15% of dietary supplements contained hormones or
prohormones. Similarly, Cohen [73] warned that potential
contaminants ranged from mere impurities to harmful
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chemicals, medications, and banned substances. Furthermore, he cautioned that the dose of these contaminants
may vary widely, from sub-therapeutic, but detectable, to
potentially toxic doses. Potent and questionably legal stimulants or stimulant derivatives may be the most common
of such culprits as they may provide additional stimulatory
effects beyond those of caffeine. Furthermore, such stimulants could reinforce supplement consumption in MIPS
users who may base supplement purchasing decisions on
the intensity of perceived stimulatory effects following ingestion. One particularly concerning report published in
2014 [69] indicated that a methamphetamine analog was
identified in a popular MIPS product, which prompted its
removal from the market by request of the FDA.
1,3-dimethylamylamine (DMAA), a similar potent sympathomimetic ingredient once found in a variety of
pre-workout supplements, was likewise removed from the
market by the FDA after being implicated as the cause of
six deaths and over 100 reported illnesses due to its detrimental effect on blood pressure and cardiac function [74].
Unsurprisingly, several unregulated DMAA analogs such as
Octodrine (2-amino-6-methylheptane) and 1,4-dimethylamylamine have recently been identified in a sample of dietary supplements [75]. Due to the reactive rather than
proactive nature of supplement regulations in the United
States, it is likely that ever-evolving iterations of experimental stimulants will be present in a variety of
products as earlier versions of these substances are
regulated and likely banned.
Thus, any athlete consuming a supplement runs the
risk of failing a drug test if components of the supplement are banned by their respective organization, which
could lead to disqualification from participation or loss
of employment. Adverse effects from consuming a supplement can result from ingestion of known ingredients
and also from any unknown contaminants or inadvertent ingestion of mega doses of the listed ingredients.
Many supplement labels list ingredients as “proprietary
blends” leaving the consumer to merely guess how much
of a given compound is in the product. This could lead
to inadvertent overdose of various ingredients, particularly if they are also being consumed in other products,
food items, or dietary supplements. As mentioned earlier, caffeine is a main ingredient in many MIPS and consumption of the substance in high doses, whether
intentional or unintentional, can result in nausea, heart
palpitations, arrhythmias, and headache [76–78]. Proper
dosage of each ingredient is critical as it pertains to
potential performance benefits and certainly as it pertains to adverse effects. When individual ingredients
found in most supplements are used at recommended
dosages, most are well tolerated. A well-respected
program, Operation Supplement Safety (OPSS.org)
has compiled a list of high risk supplements that could
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contain banned substances such as harmful stimulants,
anabolic steroids or other hormones that could negatively
affect one’s health. The concerned athlete should verify all
supplement purchases using such a method prior to consumption to ensure that risk of contamination is
minimized.
Safety of acute MIPS consumption
Blood chemistry

Jung and colleagues [60], using a MIPS that was later
tested in a chronic use study, found no changes to liver
function after acute ingestion of a single dose. However,
there was a significant group x time interaction for some
measures of kidney function (blood urea nitrogen, creatinine) in participants consuming MIPS (d = − 0.18 - 0.52,
p < 0.05, weak - moderate). These changes were expected
due to the creatine content of the supplement and were
still within normal clinical ranges. Likewise, Collins et al.
[23] noted no change in liver or kidney function markers
approximately 24 h after MIPS ingestion.
Hemodynamic response

Acute supplementation with MIPS does not appear to
adversely impact hemodynamic variables, though a variety of responses are noted. Ingestion of a caffeine-based
MIPS has been demonstrated to have no effect on heart
rate (HR), systolic blood pressure (SBP), or diastolic
blood pressure (DBP) within 30 min of ingestion [79].
Kedia et al. [3] found that ingestion of the MIPS supplement which was later banned for containing a methamphetamine analog resulted in elevations in SBP for
30–120 min post ingestion (d = 0.5–0.81, p < 0.03, moderate - strong). Another study demonstrated elevated
DBP but not SBP after MIPS ingestion (d = 15.9,
p = 0.011, strong) [4]. Several investigations have noted
higher post-exercise HR in caffeine-based MIPS users
[37, 50]. Based upon the well-documented physiological
effect of the caffeine contained in these supplements,
these responses are not unexpected, and no response
was outside an acceptable normal range. The average
time necessary for orally-ingested caffeine to reach peak
plasma concentration (~ 30–60 min) likely explains the
discrepancies between studies which saw no differences
at 30 min versus elevations at time points greater than
30 min [80].
Safety of short-term MIPS supplementation (< 10 days)
Blood chemistry

One study has investigated the safety of chronic MIPS
use for a period of less than 10 days. Collins et al. [23]
reported no difference in clinical serum or whole blood
health markers between participants using MIPS or placebo for 7 days. Short term MIPS use does not appear
to induce undesirable blood chemistry and may
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provide a favorable hormonal environment for those
trying to perform.

Hemodynamic response

Using a tilt-table, Collins and colleagues [23] performed
a hemodynamic challenge test wherein participants
rested supine for 15 min, and were then positioned vertically for 2 minutes, with HR and blood pressure being
assessed immediately before and after the 2 minutes of
vertical positioning. No unexpected results were seen,
and there were no significant differences between MIPS
and placebo with regards to HR, SBP, DBP, mean arterial
pressure (MAP), or rate pressure product (RPP).

Safety of long-term MIPS supplementation (> 10 days)
Blood chemistry

Evidence suggests that long-term MIPS supplementation
has a largely benign effect on blood chemistry parameters. Many studies have reported that long term MIPS
use has no deleterious effects on blood lipid profile
[3, 51, 54, 59, 60, 65], blood glucose [51, 54, 59, 65],
cortisol [61, 65], IGF-1 [53–55, 59, 61], liver enzymes
[51, 54, 57, 60], kidney function [3, 51, 54, 57], or
other standard blood chemistry values obtained within
a comprehensive metabolic panel [51, 53]. While Spillane
et al. [54] noted a lower basophil count among MIPS users
relative to placebo (d = − 1.06, p = 0.05, strong) following
a 28-day training program, these changes were not outside
of normal limits. Overall, these results suggest that MIPS
ingestion for greater than 10 days is unlikely to negatively
affect blood chemistry values.

Hemodynamic response

No study has found MIPS to have a different effect on
hemodynamic variables relative to placebo supplementation. Ormsbee et al. [65] found no differences in RHR,
SBP or DBP relative to placebo after supplementation
with a whey, BCAA, creatine, β-alanine, and argininebased MIPS with a protein post-workout supplement.
Kendall et al. [57] likewise noted no differences compared to placebo in RHR, SBP, DBP after 4 weeks of supplementation with a MIPS containing caffeine, creatine,
β-alanine, and amino acids. Similarly, the addition of
synephrine to a MIPS containing L-Dopa had no detectable impact on RHR, SBP, or DBP relative to placebo or
identical MIPS without synephrine [60]. Interestingly,
Kedia and colleagues [3] also found no effect of
long-term MIPS supplementation on RHR, SBP, or DBP
despite supplementing with a formulation that was demonstrated to contain methamphetamine analogs. Overall,
MIPS appears to be hemodynamically safe.
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Conclusions
Clearly, the body of literature and quality studies examining the efficacy and safety of MIPS supplementation is
preliminary at best. In this review, we have comprehensively outlined all available empirical evidence on MIPS
consumption. The majority of the current literature
would suggest that supplementation with these products
improves various types of exercise performance and can
potentiate training adaptations. Studies that directly examined safety parameters and adverse effects of MIPS
consumption concluded that short-term supplementation is safe in otherwise healthy consumers. However,
we would recommend discussing specific products and
dosages of any supplement with a knowledgeable health
professional or sports dietician prior to ingesting any
product. As stated previously, it is important to understand how different ingredients in sports supplements
may interact with prescription or over the counter medications. Using a trusted verification source and third
party testing can also help to minimize the possibility of
ingesting potentially harmful contaminants in these
products. Given the potential beneficial effects of these
supplements demonstrated in the literature to date, further investigations are warranted. Anecdotally, we know
that many people consume these products for many
years. Therefore, further research is needed to determine
the effects of chronic MIPS consumption on performance enhancement, training adaptions, and markers of
health and safety. Unfortunately, until the FDA implements additional regulations that require companies to
bring forth safety data in humans of durations longer
than 8–12 weeks, it is unlikely studies longer than this
will become available. Similarly, more information is required concerning the effects of MIPS consumption in a
wider variety of under-researched populations such as
female athletes as well as untrained adults above 40 years
of age. Further evidence concerning the effect of MIPS
supplementation on measures of sport specific performance is also needed.
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